Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Premier Health of America Inc V.PHA

Premier Health of America Inc. is a Canada-based healthtech company. The Company is a specialized healthcare services company that provides a range of staffing and outsourced service solutions for healthcare needs to governments, corporations, and individuals. The Company operates through two segments: Per Diem and Travel Nurse. The Company’s Per diem segment includes staff who work on an as... see more

TSXV:PHA - Post Discussion

Premier Health of America Inc > Estimates for Q4?
View:
Post by colourama on Nov 03, 2022 11:41pm

Estimates for Q4?

Does anyone have any estimates for the top and bottom lines in Q4? I haven't come up with any numbers but here is my list of things to look out for:

Positives:
- Full quarter of the CHCA acquisition
- Continued growth in the north
- One of the two transport contracts no longer a drag on financials (not sure if they have terminated the second)
- No further acquisition-related costs
- Costs on tech rollout finished?

Negatives:
- Higher interest rates on debt
- Soft quarter in terms of hours billed
- Inflationary pressures on wages/costs

If we weigh the positives against the negatives, what type of quarter are we expecting?

When does the selling end?
Comment by Torontojay on Nov 06, 2022 9:23am
We should get an additional $500k -$1m in revenue from the full quarter of CHCA results which should provide an added boost of up to $100k in ebitda. I expect a further decline in revenue from Code Bleu and Premier Health which may negate the revenue increase from the latest acquisition. However, Premier Health Nordik should get a nice revenue bump given the commentary on Q3.  " ...more  
Comment by colourama on Nov 09, 2022 10:17am
Torontojay, thanks for your analysis, I largely agree although I think the revenue number may be a little softer. The market is treating the company like it is going bankrupt.
Comment by stockrook86 on Nov 09, 2022 10:22am
Agreed, I think the company has great prospects with multiple tailwinds given the long-term backlogs in healthcare there should be more use of their services.  My only concern with the company overall is the debt taken on for the recent acquisiton and the fact it is floating rate. I don't think there will be any issues servicing it, but if debt markets really seize up, the lenders might ...more  
Comment by colourama on Nov 10, 2022 12:12pm
Stockrock86, I agree on all your points. The stock just doesn't seem to be able to get any support whatsoever. We are actually trading below book value now, so investors seem to think the company is unable to pay down its debt? Who knows what others are thinking, but they are probably taking large losses to try and invest somewhere else.
Comment by Torontojay on Nov 10, 2022 1:57pm
  Regarding the debt situation I'm not at all worried. Off the top of my head it's $21m in debt in $9m in cash and I think I have interest rate at 5.8% (going from memory)  At $21m in debt, interest expense is $1.21m and yes this will increase as the bank of Canada keeps raising rates which will impact the prime rates offered.  With $9m in cash, they can pay off the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities